How Has the Chondroplasty Market Size Evolved in Recent Years?
The chondroplasty market has seen considerable growth due to a variety of factors.
• The size of the chondroplasty market has experienced robust growth in the past few years. It is projected to expand from a value of $13.77 billion in 2024 through to $14.68 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.5%.
The historic growth period owes its success to multiple factors such as a higher occurrence of sports injuries, patients' inclination towards non-total joint replacement, advancements in postoperative care, enhanced provider training and expertise, as well as a rising trend in joint disorders.
What Are The Predictions for The Chondroplasty Market in the Coming Years?
The chondroplasty market is expected to maintain its strong growth trajectory in upcoming years.
• The market for chondroplasty is set to experience substantial growth in the upcoming years. Predictions estimate that by 2029 it will develop into an $18.43 billion industry, expanding at a compound annual growth rate (CAGR) of 5.9%.
Factors contributing to this growth during the forecasted period include the incorporation of regenerative medicine, a rising emphasis on outpatient procedures, the launch of innovative biomaterials, an increase in musculoskeletal disorders, and a growing elderly population. Key trends for the same period encompass the merging of technology into rehabilitation, arthroscopic methods, cartilage repair and regeneration, technological advancements in surgical tools, and the inclusion of navigation systems.
Which Drivers Are Accelerating Growth In The Chondroplasty Market?
The escalating rate of joint-related health issues is anticipated to drive the growth of the chondroplasty market. Overuse or severe injuries to a joint can lead to these health conditions, which undermine the health and functionality of the joint. Chondroplasty offers a treatment option for these disorders by mending the damaged cartilage within the joint. For example, data provided by The Lancet, a UK-based data publishing organization, in August 2023 showed that the incidence of inflammatory arthritis affecting the joint, known as gout, escalated from 1.40 diagnoses per 1,000 adults in March 2021 to 1.44 in March 2022 in the UK. Therefore, the chondroplasty market is progressively growing as the rate of joint-related health conditions continues to soar. Chondroplasty Market Influencer: Ubiquity of Knee Surgeries Boosting Chondroplasty Market's Growth
What Are The Core Segments Of The Global Chondroplasty Market?
The chondroplasty market covered in this report is segmented –
1) By Type: Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Atellar Chondroplasty, Meniscal Repair, Tissue Removal, Other Types
2) By Anatomy: Knee, Shoulder, Hip, Other Anatomies
3) By Equipment: Shavers, Radiofrequency Devices, Arthroscope, Other Equipments
4) By End Use: Hospitals, Orthopedic Clinics, Academic Research, Other End Uses
Subsegments:
1) By Radiofrequency Ablation Chondroplasty: High-Frequency Ablation, Low-Frequency Ablation
2) By Abrasion Chondroplasty: Mechanical Abrasion, Arthroscopic Abrasion
3) By Patellar Chondroplasty: Open Patellar Chondroplasty, Arthroscopic Patellar Chondroplasty
4) By Meniscal Repair: Suturing Techniques, Meniscal Allograft Transplantation
5) By Tissue Removal: Arthroscopic Debridement, Open Debridement
6) By Other Types: Microfracture Techniques, Osteochondral Autograft Transplantation
Pre-Book The Chondroplasty Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Chondroplasty Market?
Leading businesses in the chondroplasty market are developing autologous chondrocytes, utilizing the patient's own cells to improve cartilage repair. This method lowers immune rejection and aids natural regeneration, given that these cartilage cells are typically harvested from a joint's non-weight-bearing area from the patient's own body. An illustration of this came to light in August 2024 when Vericel Corporation, an American biopharmaceutical company, gained FDA approval for MACI Arthro (Matrix Autologous Chondrocyte Implantation), greatly enhancing the treatment of knee cartilage defects. MACI Arthro empowers orthopedic surgeons to operate using minimal incisions using tailor-made instruments, marking it as less invasive than older methods. This breakthrough is anticipated to better patients' recovery periods and lessen the risk of post-surgery complications.
Who Are the Key Players In The Chondroplasty Market?
Major companies operating in the chondroplasty market report are:
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• Osiris Therapeutics Inc.
• Thermo Fisher Scientific Inc.
• Takeda Pharmaceutical Company Limited
• Medtronic Public Limited Company
• Stryker Corporation
• Teva Pharmaceutical Industries Ltd.
• B. Braun Melsungen AG
• Zimmer Biomet Holdings Inc.
• Smith & Nephew PLC
• Sigma-Aldrich Corporation
• Arthrex Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• CONMED Corporation
• Promega Corporation
• Organogenesis Holdings Inc.
• Bioventus LLC
• RTI Surgical Holdings Inc.
• Vericel Corporation
• Geistlich Pharma AG
• Ocugen Inc.
• MEDIPOST Co. Ltd.
• GPC Medical Ltd.
• Sklar Surgical Instruments
• Isto Biologics
• Nebula Inc.
• NuOrtho Surgical Inc.
• Medical Devices Business Services Inc.
What Are The Regional Insights Into The Chondroplasty Market?
North America was the largest region in the chondroplasty market in 2024. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
